Nectero Medical, Inc.
Clinical trials sponsored by Nectero Medical, Inc., explained in plain language.
-
Second chance treatment aims to halt deadly aneurysm growth
Disease control Recruiting nowThis small pilot study is testing the safety and usefulness of giving a second treatment to people with an abdominal aortic aneurysm (AAA), a dangerous bulge in the body's main artery. The treatment, called the Nectero EAST System, involves injecting a special solution into the a…
Phase: NA • Sponsor: Nectero Medical, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
One-Shot treatment aims to halt dangerous aneurysm growth
Disease control Recruiting nowThis study is testing a single, minimally invasive treatment designed to stop small abdominal aortic aneurysms from growing larger and potentially rupturing. It will compare this new procedure against the current standard of care, which is regular monitoring with scans. Researche…
Phase: PHASE2, PHASE3 • Sponsor: Nectero Medical, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC